EW
GILD icon

Elyxium Wealth’s Gilead Sciences GILD Stock Holding History

Elyxium Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343K Sell
2,461
-862
-26% -$121K 0.11% 119
2025
Q4 		$408K Buy
3,323
+151
+5% +$18.4K 0.11% 119
2025
Q3 		$352K Buy
3,172
+52
+2% +$5.91K 0.12% 125
2025
Q2 		$346K Buy
3,120
+203
+7% +$21.6K 0.13% 125
2025
Q1 		$327K Buy
+2,917
New +$301K 0.14% 116

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Elyxium Wealth's GILD Position: Q1 2026 in Review

Elyxium Wealth reduced its Gilead Sciences (GILD) stake by 26% in Q1 2026, selling an estimated $121K and leaving 2,461 shares worth $343K. The position accounts for 0.11% of the portfolio, ranked #119.

Elyxium Wealth first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $408K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Elyxium Wealth held 2,461 shares of Gilead Sciences worth $343K as of Q1 2026.
  • Elyxium Wealth sold 862 Gilead Sciences shares in Q1 2026, an estimated $121K.
  • Gilead Sciences made up 0.11% of Elyxium Wealth's portfolio in Q1 2026, its #119 holding.
  • Elyxium Wealth first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Elyxium Wealth's Gilead Sciences position peaked at $408K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.